Show simple item record

The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.

dc.contributor.authorAurora-Garg, Deepti
dc.contributor.authorLu, Jia
dc.contributor.authorShih, Chie-Schin
dc.contributor.authorAdelberg, David
dc.contributor.authorCao, Z. Alexander
dc.contributor.authorFabrizio, David
dc.contributor.authorFuchs, Charles S.
dc.contributor.authorCristescu, Razvan
dc.contributor.authorKobie, Julie
dc.contributor.authorVan Cutsem, Eric
dc.contributor.authorMuro, Kei
dc.contributor.authorChung, Hyun Cheol
dc.contributor.authorOlesinski, Tomasz
dc.contributor.authorVivaldi, Caterina
dc.contributor.authorRyu, Min-hee
dc.contributor.authorMandal, Mario
dc.contributor.authorDi Bartolomeo, Maria
dc.contributor.authorBang, Yung-Jue
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorShitara, Kohei
dc.date.accessioned2021-03-02T18:31:38Z
dc.date.available2021-03-02T18:31:38Z
dc.date.issued2020
dc.identifier.citationShitara K., Ozguroglu M., Bang Y., Di Bartolomeo M., Mandal M., Ryu M., Vivaldi C., Olesinski T., Chung H. C. , Muro K., et al., "The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.", JOURNAL OF CLINICAL ONCOLOGY, cilt.38, 2020
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_b86acb14-57d9-4cad-87db-fa4da9d41a6f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/5105
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.titleThe association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume38
dc.identifier.issue15
dc.contributor.firstauthorID2281511


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record